Infinity Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Infinity Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $3.33 per share as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2023-03-28
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $3.33.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $4.15.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $4.62.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $5.31.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2022-12-31 | $3.33 10-K · filed 2023-03-28 |
| 2021-12-31 | $4.15 10-K · filed 2022-03-29 |
| 2020-12-31 | $4.62 10-K · filed 2021-03-16 |
| 2019-12-31 | $5.31 10-K · filed 2020-03-03 |
| 2018-12-31 | $6.21 10-K · filed 2019-03-14 |
| 2017-12-31 | $11.53 10-K · filed 2018-03-15 |
| 2016-12-31 | $12.46 10-K · filed 2017-03-14 |
| 2015-12-31 | $13.02 10-K · filed 2016-02-23 |
| 2014-12-31 | $12.08 10-K · filed 2015-02-24 |
| 2013-12-31 | $10.79 10-K · filed 2014-02-25 |
| 2012-12-31 | $9.00 10-K · filed 2013-03-05 |